Skip to main content
. 2022 Jun 15;31(2):e2021627. doi: 10.1590/S2237-96222022000200002

Table 2. Distribution of human anti-rabies post-exposure care (n = 4,033,098) according to epidemiological background and current prophylaxis, Brazil, 2014-2019.

Variables n %
Epidemiological background
Type of exposurea (n = 4,368,254)
Bite 3,575,717 81.9
Scratch 601,256 13.7
Lick 105,643 2.4
Indirect contact 52,294 1.2
Other 33,344 0.8
Location of the wounda (n = 4,360,995)
Hands/feet 1,541,201 35.3
Lower limbs 1,488,110 34.1
Upper limbs 704,660 16.2
Head/neck 337,007 7.7
Torso 200,210 4.6
Mucous membrane 89,807 2.1
Wound (n = 3,908,181)
Single 2,336,416 59.8
Multiple 1,541,099 39.4
Not wounded 30,666 0.8
Type of wounda (n = 3,948,063)
Surface 2,015,477 51.0
Deep 1,719,434 43.6
Laceration 213,152 5.4
Attacking animal species (n = 4,028,237)
Dog 3,281,190 81.5
Cat 612,690 15.2
Bat 31,786 0.8
Primate 19,769 0.5
Fox 5,661 0.1
Domestic herbivore 11,288 0.3
Other 65,853 1.6
Status of the animal (n = 3,872,508)
Healthy 2,762,232 71.3
Suspect 638,614 16.5
Dead/missing 455,362 11.8
Rabid 16,300 0.4
Current prophylaxis
Final status of the animal (n = 2,420,706)
Rabies negative (clinical) 2,083,834 86.1
Dead/put down/no diagnosis 283,273 11.7
Rabies negative (laboratory) 42,593 1.8
Rabies positive (clinical) 5,057 0.2
Rabies positive (laboratory) 5,949 0.2
Prophylaxis indicated (n = 3,929,787)
Observation + vaccination 1,736,036 44.2
Observation of animal 1,044,030 26.6
Vaccination 754,452 19.2
Anti-rabies serum + vaccination 329,124 8.4
Prophylaxis waived 56,850 1.4
Reexposure regimen 9,295 0.2
Prophylaxis interrupted (n = 2,226,105)
No 1,684,981 75.7
Yes 541,124 24.3
Reason for interruption (n = 541,124)
Dropout 339,356 62.7
Indicated by health center 167,363 30.9
Transfer 34,405 6.4
Active tracing, carried out by health center (n = 307,048)
Yes 236,862 77.1
No 70,186 22.9
Anti-rabies serum indicated (n = 2,133,632)
No 1,867,673 87.5
Yes 265,959 12.5

a) More than one category allowed.